Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance.
Safaroghli-Azar, Ava
Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance. [electronic resource] - European journal of pharmacology Jan 2019 - 89-98 p. digital
Publication Type: Journal Article
1879-0712
10.1016/j.ejphar.2018.10.036 doi
Aminopyridines--pharmacology
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Caspase 3--metabolism
Cell Line, Tumor
Cell Survival--drug effects
Drug Resistance, Neoplasm--drug effects
Enzyme Inhibitors--pharmacology
G2 Phase Cell Cycle Checkpoints--drug effects
Gene Expression Regulation, Neoplastic--drug effects
Humans
M Phase Cell Cycle Checkpoints--drug effects
Morpholines--pharmacology
Multiple Myeloma--pathology
Phosphoinositide-3 Kinase Inhibitors
Tumor Protein p73--metabolism
Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance. [electronic resource] - European journal of pharmacology Jan 2019 - 89-98 p. digital
Publication Type: Journal Article
1879-0712
10.1016/j.ejphar.2018.10.036 doi
Aminopyridines--pharmacology
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Caspase 3--metabolism
Cell Line, Tumor
Cell Survival--drug effects
Drug Resistance, Neoplasm--drug effects
Enzyme Inhibitors--pharmacology
G2 Phase Cell Cycle Checkpoints--drug effects
Gene Expression Regulation, Neoplastic--drug effects
Humans
M Phase Cell Cycle Checkpoints--drug effects
Morpholines--pharmacology
Multiple Myeloma--pathology
Phosphoinositide-3 Kinase Inhibitors
Tumor Protein p73--metabolism